Eli Lilly (LLY)
(Delayed Data from NYSE)
$762.66 USD
+8.49 (1.13%)
Updated Mar 18, 2024 04:00 PM ET
After-Market: $762.65 -0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
LLY 762.66 +8.49(1.13%)
Will LLY be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for LLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LLY
Madrigal (MDGL) Stock Up as FDA Approves First Drug for NASH
Pharma Stock Roundup: AZN's New Acquisition, FDA Updates for NVO & LLY and More
LLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Amazon (AMZN) Boosts Pharmacy Efforts With Lilly's Partnership
Lilly (LLY) Partners Amazon to Deliver Drugs Like Zepbound
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
Other News for LLY
10 Health Care Stocks Whale Activity In Today's Session
Oprah expected to endorse WeightWatchers Clinic on ABC special
Eli Lilly Stock (NYSE:LLY): Bullish on Innovation and Pharmaceutical Success
AstraZeneca to cap costs of inhalers at $35 per month
Oprah to host TV special discussing weight loss, CNN reports